NCT00427765View on ClinicalTrials.gov

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Multiple MyelomaLymphoma
Interventions
DRUG

Busulfan

Test Dose = 32 mg/m\^2 IV for 1 Day; 130 mg/m\^2 IV for 4 Days

DRUG

Melphalan

70 mg/m\^2 IV for 2 Days

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00427765 - Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma | Biotech Hunter | Biotech Hunter